Measures of cognitive function and work in occupationally active breast cancer survivors

Journal of Occupational and Environmental Medicine

Volumn 52, Issue 2, 2010, Pages 219-227

  Calvio, Lisseth ^a   Peugeot, Mark ^a   Bruns, Gina L ^a,b   Todd, Briana L ^a   Feuerstein, Michael ^a,c  

^a Uniformed Services University of the Health Sciences   (United States)

^b AMERICAN UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISTRESS SYNDROME; FATIGUE; FEMALE; HUMAN; JOB STRESS; WORKING MEMORY;

EID: 77049093021     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181d0bef7     Document Type: Article

References (68)

1. Amir Z, Neary D, Luker K. Cancer survivors' views of work 3 years post diagnosis: a UK perspective. Eur J Oncol Nurs. 2008;12:190-197.
2. de Boer AGEM, Taskila T, Ojajarvi A, van Dijk FJH, Verbeek JHAM. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301:753-762.
3. Bradley CJ, Bednarek HL. Employment patterns of long-term cancer survivors. Psychooncology. 2002;11:188-198.
4. Maunsell E, Drolet M, Brisson J, Brisson C, Masse B, Deschenes L. Work situation after breast cancer: results from a population-based study. J Natl Cancer Inst. 2004;96:1813-1822.
5. Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103:1292-1301.
6. Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care (Engl). 2007;16:17-25.
7. Feuerstein M, Luff GM, Harrington CB, Olsen CH. Pattern of workplace disputes in cancer survivors: a population study of ADA claims. J Cancer Surviv. 2007;1:185-192.
8. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer. 2006;106:751-758.
9. Helgeson V, Tomich P. A comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology. 2005;14:307-317.
10. Gandubert C, Carriere I, Escot C, et al. Onset and relapse of psychiatric disorders following early breast cancer: a case-control study. Psychooncology. 2009;18: 1029-1037.
11. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292-2299.
12. Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer. 2004;91:822-828.
13. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psychooncology. 2006;15:306-320.
14. Finnegan L, Campbell R, Ferrans C, Wilbur J, Wilkie D, Shaver J. Symptom cluster experience profiles in adult survivors of childhood cancers. J Pain Symptom Manag. 2009;38:258-269.
15. Hansen J, Feuerstein M, Calvio LC, Olsen C. Breast cancer survivors at work. J Occup Environ Med. 2008;50:777-784.
16. Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorditiy. J Am Board Fam Med. 2007;20:434-443.
17. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20:76-89.
18. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005;59:60-70.
19. Vardy J, Wefel JS, Ahles TA, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. 2008;19:623-629.
20. Boykoff N, Moieni M, Subramanian SK. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. J Cancer Surviv. 2009;3:223-232.
21. Munir F, Yarker J, McDermmot H. Employment and the common cancers: correlates of work ability during or following cancer treatment. Occup Med (Lond). 2009;59:381-389.
22. Silverman DHS, Dy CJ, Castellon SA, et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res Treat. 2007;103:303-311.
23. Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002;20:485-493.
24. Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol. 2008;26:768-777.
25. Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of noncentral nervous system cancer and cancer therapy. Neuropsychol Rev. 2008;18:121-131.
26. Fan HG, Houede-Tchen N, Yi QL, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005;23:8025-8032.
27. Valentine AD, Meyers CA. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer. 2001;92(6 Suppl):1694-1698.
28. Roth RS, Geisser ME, Theisen-Goodvich M, Dixon PJ. Cognitive complaints are associated with depression, fatigue, female sex, and pain catastrophizing in patients with chronic pain. Arch Phys Med Rehabil. 2005;86: 1147-1154.
29. Poppelreuter M, Weis J, Kulz AK, Tucha O, Lange KW, Bartsch HH. Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre. Eur J Cancer. 2004;40:43-49.
30. Tannock IF, Ahles TA, Ganz PA, Van Dam FS. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22:2233-2239.
31. SPSS for Windows, Rel. 17.0.0. Chicago: SPSS Inc.; 2008.
32. Scott J, Huskisson EC. Vertical or horizontal visual analogue scales. Ann Rheum Dis. 1979;38:560.
33. Maunsell E, Drolet M, Ouhoummane N, Robert J. Breast cancer survivors accurately reported key treatment and prognostic characteristics. J Clin Epidemiol. 2005;58:364-369.
34. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
35. Hopwood P, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer. 1991;64:353-356.
36. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003;54:269-282.
37. Michopoulos I, Douzenis A, Kalkavoura C, et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry. 2008;7:4.
38. Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage. 2004;27:14-23.
39. Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist. 2007;12(Suppl 1):11-21.
40. Gift AG. Visual analogue scales: measurement of subjective phenomena. Nurs Res. 1989;38:286-287.
41. Brunier G, Graydon J. A comparison of two methods of measuring fatigue in patients on chronic haemodialysis: visual analogue vs Likert scale. Int J Nurs Stud. 1996;33:338-348.
42. Calvio LC, Feuerstein M, Hansen J, Luff GM. Cognitive limitations in occupationally active brain tumor survivors. Occup Med (Lond). 2009;59: 406-412.
43. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance Systems Survey Questionnaire: US Department of Health and Human Services. Atlanta, GA: Centers for Disease Control and Prevention; 1999.
44. Feuerstein M, Hansen JA, Calvio LC, Johnson L, Ronquillo JG. Work productivity in brain tumor survivors. J Occup Environ Med. 2007;49:803-811.
45. Newhouse PA, Potter A, Singh A. Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol. 2004;4:36-46.
46. Peeling P, Dawson B. Influence of caffeine ingestion on perceived mood states, concentration, and arousal levels during a 75-min university lecture. Adv Physiol Educ. 2007;31:332-335.
47. Weissenborn R, Duka T. Acute alcohol effects on cognitive function in social drinkers: their relationship to drinking habits. Psychopharmacology (Berl). 2003;156:306-312.
48. Baraona E, Abittan CS, Dohmen K, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 2001;25:502-507.
49. O'Hara C, Harrell M, Bellingrath E, Lisicia K. Cognitive Symptom Checklists- Clinician's Guide. Florida: Psychological Assessment Resources, Inc.; 1993.
50. Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS vital signs. Arch Clin Neuropsychol. 2006;21:623-643.
51. Lerner D, Amick BC III, Rogers WH, Malspeis S, Bungay K, Cynn D. The work limitations questionnaire. Med Care. 2001;39:72-85.
52. Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am J Manag Care. 2007;13: 211-217.
53. Lofland JH, Pizzi L, Frick KD. A review of health-related workplace productivity loss instruments. Pharmacoeconomics. 2004;22:165-184.
54. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics. 2004;22:225-244.
55. Amick BC III, Lerner D, Rogers WH, Rooney T, Katz JN. A review of health-related work outcome measures and their uses, and recommended measures. Spine. 2000;25:3152-3160.
56. Allen HM Jr, Bunn WB III. Validating self-reported measures of productivity at work: a case for their credibility in a heavy manufacturing setting. J Occup Environ Med. 2003;45:926-940.
57. Lerner D, Amick BC III, Lee JC, et al. Relationship of employee-reported work limitations to work productivity. Med Care. 2003;41:649-659.
58. Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs. 2007;11:6-15.
59. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008;13:1285-1295.
60. Parasuraman R, Rizzo M, eds. Neuroergonomics: The Brain at Work. New York: Oxford University Press; 2008.
61. Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol. 2007;25:3866-3870.
62. Brown LF, Kroenke KK. Cancer-related fatigue and its associations with depression and anxiety: a systematic review. Psychosomatics. 2009;50:440-447.
63. Whitehead LC. Methodological and ethical issues in Internet-mediated research in the field of health: an integrated review of the literature. Soc Sci Med. 2007;65:782-791.
64. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2006.
65. American Cancer Society. Breast Cancer Facts & Figures 2005-2006. Atlanta, GA: American Cancer Society, Inc.; 2005.
66. Feuerstein M, ed. Work and Cancer Survivors. New York: Springer-Verlag; 2009.
67. Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8:887-899.
68. Dantzer R, Capuron L, Irwin MR, et al. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology. 2008;33:18-29.